PINT has released a redesigned interactive web site (www.flutest.com) for Quidel Corporation (Nasdaq:QDEL), a leading provider of rapid point-of-care diagnostic tests.

The new site delivers practical flu solutions for consumers and the latest information about influenza, including vaccine-related issues, rapid diagnostic tests and treatment options.

PINT developed the following site features and consumer engagement tools:

• Find-a-Doctor - Allows consumers to quickly locate a local physician offering the QuickVue® Influenza test
• Flu Facts - Information about the virus and treatments available
• CDC Surveillance Map - Highlights states that are experiencing outbreaks and demonstrates the severity of the virus' spread

"We felt it was important to highlight the very critical role rapid flu testing may have this flu season. We take very seriously our responsibility as the innovator and market leader in flu testing to provide timely educational outreach to the public about the critical issues surrounding the flu," said Caren L. Mason, president and CEO of Quidel.

About Quidel
Quidel Corporation is a global company dedicated to helping women and their families live healthy lives through the discovery, development, manufacture and marketing of rapid point-of-care (POC) diagnostic tests. These tests detect medical conditions and illnesses associated with women's health in areas such as reproduction and diseases of the elderly. Quidel also provides POC diagnostic tests for infectious diseases, including influenza A & B, Strep A, H. pylori, Chlamydia, infectious mononucleosis and infectious vaginitis. Quidel's diagnostic tests provide information that results in rapid treatment, improved health outcomes, lowered costs and increased patient satisfaction. Quidel's products are sold for use in physician offices, clinical laboratories and pharmacies, and to consumers through organizations that provide private label products. For more information visit www.quidel.com.